Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Lexicon Pharmaceuticals (Nasdaq: LXRX) has scheduled the release of its fourth quarter and full year 2024 financial results for Thursday, March 6, 2025, after market close. The company will host a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) on the same day to discuss the financial performance and provide a business update.
Investors can access the conference call through the Events page on Lexicon's investor website. Those interested in asking questions during the call can register to receive dial-in information and a unique PIN. An archived version of the webcast will be available for later viewing on the company's website.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha programmato la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024 per giovedì 6 marzo 2025, dopo la chiusura del mercato. L'azienda ospiterà una teleconferenza e una diretta web alle 17:00 ET (16:00 CT) dello stesso giorno per discutere le performance finanziarie e fornire un aggiornamento aziendale.
Gli investitori possono accedere alla teleconferenza tramite la pagina Eventi sul sito web per gli investitori di Lexicon. Coloro che sono interessati a porre domande durante la chiamata possono registrarsi per ricevere le informazioni di accesso e un PIN unico. Una versione archiviata della diretta sarà disponibile per la visione successiva sul sito web dell'azienda.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para jueves, 6 de marzo de 2025, después del cierre del mercado. La compañía realizará una conferencia telefónica y una transmisión web en vivo a las 5:00 p.m. ET (4:00 p.m. CT) el mismo día para discutir el rendimiento financiero y proporcionar una actualización empresarial.
Los inversores pueden acceder a la conferencia telefónica a través de la página de Eventos en el sitio web para inversores de Lexicon. Aquellos interesados en hacer preguntas durante la llamada pueden registrarse para recibir información de acceso y un PIN único. Una versión archivada de la transmisión estará disponible para su visualización posterior en el sitio web de la compañía.
Lexicon Pharmaceuticals (Nasdaq: LXRX)는 2024년 4분기 및 전체 연도 재무 결과를 2025년 3월 6일 목요일에 시장 마감 후 발표할 예정입니다. 회사는 같은 날 오후 5시 ET (오후 4시 CT)에 재무 성과를 논의하고 비즈니스 업데이트를 제공하기 위해 컨퍼런스 콜과 라이브 웹캐스트를 개최합니다.
투자자는 Lexicon의 투자자 웹사이트의 이벤트 페이지를 통해 컨퍼런스 콜에 접근할 수 있습니다. 통화 중 질문을 하고자 하는 분들은 전화 접속 정보와 고유한 PIN을 받기 위해 등록할 수 있습니다. 웹캐스트의 아카이브 버전은 회사 웹사이트에서 나중에 시청할 수 있습니다.
Lexicon Pharmaceuticals (Nasdaq: LXRX) a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour jeudi 6 mars 2025, après la fermeture du marché. L'entreprise organisera une conférence téléphonique et un webinaire en direct à 17h00 ET (16h00 CT) le même jour pour discuter de la performance financière et fournir une mise à jour sur les activités.
Les investisseurs peuvent accéder à la conférence téléphonique via la page Événements sur le site des investisseurs de Lexicon. Ceux qui souhaitent poser des questions lors de l'appel peuvent s'inscrire pour recevoir les informations de connexion et un code PIN unique. Une version archivée du webinaire sera disponible ultérieurement sur le site de l'entreprise.
Lexicon Pharmaceuticals (Nasdaq: LXRX) hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Donnerstag, den 6. März 2025, nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 17:00 Uhr ET (16:00 Uhr CT) eine Telefonkonferenz und einen Live-Webcast abhalten, um die finanzielle Leistung zu erörtern und ein Unternehmensupdate zu geben.
Investoren können über die Veranstaltungsseite auf der Investorenseite von Lexicon auf die Telefonkonferenz zugreifen. Interessierte, die während des Anrufs Fragen stellen möchten, können sich registrieren, um Zugangsinformationen und eine eindeutige PIN zu erhalten. Eine archivierte Version des Webcasts wird später auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
THE WOODLANDS, Texas, March 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025 after the markets close. Management will conduct a conference call and live webcast at 5:00 p.m. ET (4:00 p.m. CT) that day to discuss the financial results and to provide a business update.
Participants can access the conference call live via webcast on the Events page of the Company’s website at https://investors.lexpharma.com/. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. An archived version of the webcast will be available on the Lexicon website.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
When will Lexicon Pharmaceuticals (LXRX) release Q4 and full-year 2024 earnings?
What time is LXRX's Q4 2024 earnings conference call?
How can investors access LXRX's Q4 2024 earnings call?
Will LXRX's Q4 2024 earnings call be available for replay?
